Zack Scott
General Partner·Norwest
Dr. Zack Scott is a General Partner and Co-Head of the healthcare investment team at Norwest. He serves on the boards of Apreo Health, Cytovale, Galvanize Therapeutics, Nectero Medical, SetPoint Medical, and ShiraTronics, and is a board observer at VenoStent. Before Norwest, he co-founded and was managing partner of Revelation Partners, where he made healthcare investments including Omada Health, iRhythm Technologies, SetPoint Medical, and Respicardia.
See the rest of Zack Scott's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.